Amino-acid chains
Examples in this catalog include MOTS-c, GHK-Cu, Semax, Selank, and tesamorelin. Each has its own evidence, status, and intended context.
RESEARCH EDUCATION / PEPTIDE FUNDAMENTALS
Understand the research category.
Peptides and related research compounds are not interchangeable. This guide explains classification, signaling concepts, evidence levels, and how to evaluate laboratory product information without turning research findings into consumer treatment claims.
Educational concept graphic • use page text for precise context01 / WHAT ARE PEPTIDES?Short chains.
Short chains.
Specific sequences.
Peptides are molecules made from amino acids linked by peptide bonds. They are generally shorter than proteins, and their biological behavior depends on the exact amino-acid sequence and structure.
Some peptides occur naturally in the human body and participate in signaling or regulation. Others are manufactured for approved medicines, diagnostics, cosmetics, or laboratory research. That range is why the name of the specific compound matters more than the category label alone.
AMINO ACIDSThe individual building blocks.
PEPTIDE BONDThe chemical link joining amino acids together.
SEQUENCEThe order of amino acids can change how a peptide behaves.
02 / CLASSIFICATION MATTERS
Not everything in the catalog is a peptide.
Accurate classification keeps the science language honest. Several research products are commonly discussed alongside peptides even though they belong to different chemical categories.
NAD+
NAD+ participates in cellular redox reactions and energy metabolism. It is not a peptide and should not be described as one.
5-Amino-1MQ
5-Amino-1MQ is a small-molecule research compound associated with NNMT research. It is not a peptide.
Bacteriostatic water
Bacteriostatic water is a sterile diluent category, not an active wellness ingredient and not a peptide.
03 / HOW PEPTIDES WORK
Signals are only useful when the right receptor responds.
Many peptides act by interacting with receptors or other biological targets. The downstream response depends on the molecule, receptor, tissue, dose, route, and physiological context.
Educational concept graphic • not a treatment claimSignal
A specific peptide reaches a biological target such as a receptor.
Recognition
The target recognizes particular structural features of the molecule.
Response
Receptor activation or another interaction can start a downstream cellular pathway.
Outcome
The observed effect depends on the compound and the quality of the evidence supporting that use.
Related chemistry, different scale.
Both peptides and proteins are built from amino acids. Proteins are typically larger and often fold into complex three-dimensional structures. Peptides are shorter, but “shorter” does not mean weaker, safer, or interchangeable.
The name of the compound matters.
Two products can both be called peptides while acting through very different pathways. Claims should therefore be compound-specific, formulation-specific, and supported by the relevant evidence.
04 / RESEARCH PATHWAYS
Why products are grouped by research context.
Categories such as metabolic, beauty, cognitive, recovery, and cellular are navigation tools—not guarantees of outcomes. They help organize the catalog while each product page explains its own status.
Metabolic energy metabolism, glucose signaling, or body-composition researchBiomaterials / skin biology collagen, extracellular-matrix, or pigmentation researchCognitive neurological and stress-response researchRecovery tissue, growth-hormone, or repair-related pathwaysCellular redox, mitochondrial, and energy-metabolism context
Navigation concept • product-specific status appears on each profile05 / HOW STRONG IS THE EVIDENCE?
Research exists on a spectrum.
Evidence quality is not binary. A compound may have an approved medical use, human clinical studies for another question, early-stage research, or mainly preclinical data.
Approved use
An approved drug has a defined label for specific indications, dosing, formulation, and safety information. Approval of one branded drug does not make every product containing the same named ingredient an approved drug.
Clinical research
Human studies can provide useful information, but study design, population, formulation, dose, duration, and endpoints determine what conclusions are reasonable.
Investigational
Some compounds are being studied but do not have an established approved use. Marketing should not turn an investigational finding into a guaranteed consumer benefit.
Laboratory or animal data
Preclinical results can guide research questions, but they do not automatically predict effectiveness or safety in people.
06 / WHY FORMULATION DETAILS MATTER
The compound name is only part of the story.
Quality and interpretation depend on the actual material being offered, not just the headline name.
Salt form, excipients, blend composition, and concentration can change how a product should be evaluated.
Topical, oral, nasal, injectable, and other routes are not interchangeable and can have different evidence and safety considerations.
Identity, purity, concentration, sterility where applicable, storage, and traceability are separate quality questions.
Legal availability, prescription requirements, and investigational status can differ by compound and jurisdiction.
07 / QUALITY / COARead the product page.
Read the product page.
Then read the document.
A Certificate of Analysis can provide batch-specific analytical information, but it does not by itself establish approval, clinical effectiveness, safe use, or sterility unless those items are specifically and appropriately tested.
IMPORTANT CONTEXT
Research education is not human-use guidance.
This page is designed to explain terminology used in research literature and product documentation. It does not authorize human or veterinary use, diagnose a condition, recommend treatment, prescribe a product, provide dosing or administration instructions, or establish that a research material is safe or effective for clinical use.